Deficiency of ectodysplasin A1 (EDA1) due to variants of the gene EDA causes X-linked hypohidrotic ectodermal dysplasia (XLHED), a rare genetic condition characterized by abnormal development of ectodermal structures. XLHED is defined by the triad of hypotrichosis, hypo- or anhidrosis, and hypo- or anodontia. Anhidrosis may lead to life-threatening hyperthermia. A definite genetic diagnosis is, thus, important for the patients’ management and amenability to a novel prenatal treatment option. Here, we describe five familial EDA variants segregating with the disease in three families, for which different prediction tools yielded discordant results with respect to their significance. Functional properties in vitro and levels of circulating serum EDA were compared with phenotypic data on skin, hair, eyes, teeth, and sweat glands. EDA1-Gly176Val, although associated with relevant hypohidrosis, still bound to the EDA receptor (EDAR). Subjects with EDA1-Pro389LeufsX27, -Ter392GlnfsX30, -Ser125Cys, and an EDA1 splice variant (c.924+7A > G) showed complete absence of pilocarpine-induced sweating. EDA1-Pro389LeufsX27 was incapable of binding to EDAR and undetectable in serum. EDA1-Ter392GlnfsX30, produced in much lower amounts than wild-type EDA1, could still bind to EDAR, and so did EDA1-Ser125Cys that was, however, undetectable in serum. The EDA splice variant c.924+7A > G resulted experimentally in a mix of wild-type EDA1 and EDA molecules truncated in the middle of the receptor-binding domain, with reduced EDA serum concentration. Thus, in vitro assays reflected the clinical phenotype in two of these difficult cases, but underestimated it in three others. Absence of circulating EDA seems to predict the full-blown phenotype of XLHED, while residual EDA levels may also be found in anhidrotic patients. This indicates that unborn subjects carrying variants of uncertain significance could benefit from an upcoming prenatal medical treatment even if circulating EDA levels or tests in vitro suggest residual EDA1 activity.
Öz Stafilokoksik haşlanmış deri sendromu (SHDS) Staphylococcus aureus eksfolyatif toksininın yol açtığı nadir bir hastalıktır. İnsidansı yılda bir milyonda 0.09 ila 0.13 arasında değişmektedir. İmmünyetmezlikli bireylerdeki insidansı ise bilinmemektedir ancak çok nadir olduğu tahmin edilebilir. Bu konuda yetişkin hastalarda çok az olgu bildirilmiştir. Bu yazıda, febril nötropeni atağı sırasında süpüratif otitis media sonrası SHDS gelişen akut lenfositik lösemi tanılı bir çocuk hasta sunulmuştur.
Stafilokoksik haşlanmış deri sendromu (SHDS) Staphylococcus aureus eksfolyatif toksininin yol açtığı nadir bir hastalıktır. İnsidansı yılda bir milyonda 0.09 ila 0.13 arasında değişmektedir. İmmünyetmezlikli bireylerdeki insidansı ise bilinmemektedir ancak çok nadir olduğu tahmin edilebilir. Bu konuda yetişkin hastalarda çok az olgu bildirilmiştir. Bu yazıda, febril nötropeni atağı sırasında süpüratif otitis media sonrası SHDS gelişen akut lenfositik lösemi (ALL) tanılı bir çocuk hasta sunulmuştur.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.